Doctor profile · Federal record
Dr. Lois Kamugisha
Medical Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Hematology (Internal Medicine) Physician · Hematology & Oncology Physician · Northampton, MA
- NPI 1134396948
- Accepts Medicare
- 29 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
30 Locust St
Northampton, MA 010602052
(413) 582-2900
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- August 1, 2025
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State licenses (3)
- Massachusetts #1020409 · Delaware #C1-0024842 · Kentucky #TP419
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134396948. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
32,890
Distinct HCPCS
10
Medicare allowed
$259,608
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 24,750 | 19 | $1 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,290 | 22 | $7 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,910 | 12 | $45 | |
J0897 |
Injection, denosumab, 1 mg | 1,620 | 12 | $23 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 750 | 16 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 322 | 12 | $0 | |
96372 |
Injection of drug or substance under skin or into muscle | 311 | 104 | $15 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 310 | 148 | $135 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 104 | 57 | $70 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 64 | 18 | $22 |
In context: peer comparison
Among 1 peers in Northampton Medical Oncology Physician, average services per provider: 1,370. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$1,084
Transactions
43
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $216.90 | |
| Celgene Corporation | 5 | $103.81 | |
| Rigel Pharmaceuticals, INC. | 6 | $91.06 | |
| Jazz Pharmaceuticals INC. | 3 | $62.26 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $55.55 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $54.23 | |
| Daiichi Sankyo INC. | 2 | $51.92 | |
| Bayer Healthcare Pharmaceuticals INC. | 2 | $50.36 | |
| Exelixis INC. | 2 | $42.81 | |
| Merck Sharp & Dohme LLC | 2 | $38.99 | |
| PharmaEssentia USA Corporation | 2 | $38.11 | |
| Novocure INC. | 1 | $34.95 | |
| Takeda Pharmaceuticals U.S.A., INC. | 2 | $33.09 | |
| Mirati Therapeutics, INC. | 1 | $29.92 | |
| Incyte Corporation | 2 | $28.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
87
Patients
11
Total drug cost
$28,606
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 35 | 11 | $27,565 |
| Acyclovir | Generic | 16 | 0 | $168 |
| Hydroxyurea | Generic | 14 | 0 | $514 |
| Anastrozole | Generic | 11 | 0 | $312 |
| Prednisone | Generic | 11 | 0 | $47 |
Hospital affiliations
Frequently asked questions
What is Dr. Lois Kamugisha's medical specialty?
Dr. Lois Kamugisha practices Medical Oncology Physician in Northampton, MA.
Where does Dr. Lois Kamugisha practice?
Dr. Lois Kamugisha practices at 30 Locust St, Northampton, MA 010602052. Office phone: 4135822900.
What is Dr. Lois Kamugisha's NPI?
Dr. Lois Kamugisha's National Provider Identifier (NPI) is 1134396948, issued by NPPES.
Does Dr. Lois Kamugisha accept Medicare assignment?
Yes. Dr. Lois Kamugisha accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lois Kamugisha commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS J0885); Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS J1569). Source: CMS Medicare Physician & Other Practitioners file.